CD8A and neoplasm: PD-1 inhibitors restore the ability of immune cells, such as CD4 + T cells, CD8 + T cells, and natural killer cells, to recognize and kill tumor cells by blocking the binding of PD-1 to the membrane of immune cells and PD-L1 expressed on the membrane of tumor cells (18).